Chargement en cours...
Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.
Carbogen and nicotinamide have been evaluated in a phase II study as hypoxia-modifying agents during radical radiotherapy for bladder cancer using a standard daily 20-fraction schedule. Three groups of patients have received (a) nicotinamide alone, given orally in a dose of 80 mg kg(-1) daily with 5...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
1997
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2223941/ https://ncbi.nlm.nih.gov/pubmed/9231929 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|